Evidence map›Paper›PMID 40675326›Full record

Trial reportThe journal of allergy and clinical immunology. In practice2025

The Pragmatic Removal of Penicillin Allergy Electronic Health Record Labels (PROPEL) Trial: A Randomized Clinical Trial.

Cosby A Stone, Heather L Prigmore, Allison B McCoy, Joanna L Stollings, Mary Lynn Dear, William Hiser, Grace Van Winkle, Sunil Kripalani, Adam Wright, Frank E Harrell and 4 more

Abstract readRandomized Controlled TrialPragmatic Clinical Trial
In one paragraph

Trial report in The journal of allergy and clinical immunology. In practice, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Trial
  2. Institutional Trends in Penicillin Allergy: A New Era of Active Penicillin Allergy Delabeling.Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology · 2026
    Article
  3. Inpatient Penicillin Allergy Delabeling: "How Soon Can We Get Started?"The journal of allergy and clinical immunology. In practice · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Cosby A StoneDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn. Electronic address: cosby.a.stone@vumc.org.
Heather L PrigmoreDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tenn.
Allison B McCoyDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tenn.
Joanna L StollingsDepartment of Pharmaceutical Services, Vanderbilt University Medical Center, Nashville, Tenn.
Mary Lynn DearVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tenn.
William HiserVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tenn.
Grace Van WinkleVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tenn.
Sunil KripalaniDepartment of Medicine, Vanderbilt University Medical Center, Nashville, Tenn; Center for Health Services Research, Vanderbilt University Medical Center, Nashville, Tenn.
Adam WrightDepartment of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tenn.
Frank E HarrellDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tenn.
Todd W RiceDivision of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tenn; Vanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tenn.
Christopher J LindsellDepartment of Biostatistics, Vanderbilt University Medical Center, Nashville, Tenn; Department of Biomedical Informatics, Vanderbilt University Medical Center, Nashville, Tenn; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC.
Elizabeth J PhillipsDepartment of Pharmacology, Vanderbilt University School of Medicine, Nashville, Tenn; Department of Pathology, Microbiology, and Immunology, Vanderbilt University School of Medicine, Nashville, Tenn; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Perth, Western Australia.
Vanderbilt Learning Healthcare System Platform InvestigatorsVanderbilt Institute for Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, Tenn.

Funding

AHRQ HHS K12 HS026395AHRQ HHS R01 HS030234
6 · The paper itself

Abstract

backgroundInaccurate penicillin allergy labels (PALs) affect antimicrobial stewardship, health outcomes, and costs. More than 95% of PALs can be de-labeled when tested, but this rarely happens.

objectiveWe sought to determine whether education and an electronic health record (EHR) tool kit to identify low-risk PALs would facilitate inpatient penicillin allergy de-labeling by pharmacists.

methodsPragmatic Removal of Penicillin Allergy Electronic Health Record Labels was a stepped-wedge, nonblinded, randomized, controlled, pragmatic clinical trial including 12 inpatient medical units. From November 2020 to November 2021, units entered intervention at 1-month stepped intervals in random order. Medically stable, nonpregnant adults with an her-documented PAL who were hospitalized on intervention units for 24 hours were included. The intervention included pharmacist and nursing education, a patient list for systematic identification of PALs, presentation of a risk-assessment tool, and an oral amoxicillin challenge order set. The primary outcome was removal of PAL by hospital discharge. Secondary outcomes included safety and implementation measures, longer-term continued label removal, and antibiotic use.

resultsOn 12 randomized units, 2,052 patients with a PAL presented during the 1-year trial. More intervention-exposed patients had EHR-documented penicillin allergy removal compared with controls (45 of 1,018 [4.4%] vs 31 of 1,034 [3%], respectively; adjusted odds ratio = 2.05; 95% CI, 1.08-3.91). More intervention-exposed patients received an EHR-documented penicillin allergy risk assessment than did controls (86 of 1,018 [8.4%] vs 27 of 1,034 [2.6%]; adjusted odds ratio = 6.42; 95% CI, 3.08-13.38). Moreover, 27 of 1,018 intervention patients (2.7%) received amoxicillin challenge compared with 21 of 1,034 control patients (2.0%). All amoxicillin challenges were tolerated.

conclusionEducation and deployment of an inpatient EHR tool kit increased the rate of inpatient removal of inaccurate penicillin allergies before discharge.

Indexed as

Anti-Bacterial AgentsDrug HypersensitivityDrug LabelingElectronic Health RecordsPenicillinsAdultAgedAmoxicillinAntimicrobial StewardshipFemaleHumansMaleMiddle AgedAmoxicillinAnti-Bacterial AgentsPenicillinsAllergyDe-labelingHospitalImplementationInpatientPenicillinPharmacistRCTTrial

Identifiers

PMID40675326
PMCPMC12974585

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.